Table of Contents Table of Contents
Previous Page  286 / 435 Next Page
Information
Show Menu
Previous Page 286 / 435 Next Page
Page Background

J

IANMING

T

AO

page 4 of 4…

jtao@spectrixservices.com

P

UBLICATIONS

Tao J.

, Arias-Salgado E.G., Gonzalez-Manchon C., Diaz-Cremades J., Ayuso M.S., and Parrilla R. A

novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombasthenia

.

Br.

J. Haematol.,

111(1):96-103, 2000.

Tao, J.

, and Parrilla, R. cDNA sequences for GPIIb and GPIIIa of species. GI: 5733733 (dog GPIIb), GI:

5805336 (pig GPIIb), GI: 5805340 (rabbit GPIIb), GI: 5733735 (dog GPIIIa), GI: 5805338 (pig

GPIIIa), and GI: 5805342 (rabbit GPIIIa). Published in GenBank, 1999.

Ferrer, M.,

Tao, J.

, Iruin, G., Sanchez-Ayuso, M., Gonzalez-Rodriguez, J., Parrilla, R., and Gonzalez-

Manchon, C. Truncation of glycoprotein (GP) IIIa (del616-762) prevents complex formation with

GPIIb: Novel mutation in exon 11 of GPIIIa associated with thrombasthenia. Blood, 92(12):4712-

4720, 1998.

Ibarreta, D.,

Tao, J.

, Parrilla, R., and Ayuso, M.S. Mutation analysis of chromosome 19 calmodulin

(CALM3) gene in Alzheimer's disease patients. Neurosci. Lett., 299:157-160, 1997.

Ferrer, M.,

Tao, J.

, Menaya, J., Gonzalez-Manchon, C., Fernandez, M., Alvarez, M.V., Garcia-Munoz, M.,

Ayuso, M.S., and Parrilla, R. A novel point mutation in the GPIIIa subunit of the integrin alphaIIbbeta3

associated to Glanzmann's thrombasthenia. In Advances in Gene Technology. Therapeutic Strategies in

Molecular Medicine. Ahmad F, etc. Eds. (Oxford: Oxford University Press), 1996.

Ye, Q., Zhang, S.L., Lu, S.C.,

Tao, J.M.

, and Yu, J.T. Interferon gamma production in

E. coli

DH5alpha

(pBV220). Better Living Through Innovative Biochemical Engineering (Proceedings of the 3rd Asia-

Pacific Biochemical Engineering Conference), pp. 140, Singapore, 1994.

Lu, S.C.,

Tao, J.M.

, Qiu, W.R., and Yu, J.T. Propylene oxide production from propylene by immobilized

whole cell of methanotroph Z201 (in Chinese). Huadong Ligong Daxue Xuebao (Journal of ECUST),

20(1):21-26, 1994.

Ye, Q.,

Tao, J.M.

, Zhang H., Zhang S.L., Cai, H.B., Bao, W.G., and Li Y.Y. Human alpha atrial

natriuretic peptide fermentation by using a genetically engineered yeast strain (in Chinese). Shengwu

Gongcheng Xuebao (Chinese Journal of Biotechnology), 10(4):312-317, 1994.

Ye, Q.,

Tao, J.M.

, Zhang, S.L., and Yu, J.T. Production of human atrial natriuretic peptide by a

recombinant yeast strain. Better Living Through Innovative Biochemical Engineering (Proceedings of

the 3rd Asia-Pacific Biochemical Engineering Conference), pp. 143, Singapore, 1994.

Tao, J.M.

, Ye, Q., Qi, L.H., and Zhang, S.L. Human alpha atrial natriuretic peptide production using a

genetically engineered yeast strain (in Chinese). Proceedings of the 5th National Symposium on

Biotechnology and Bioengineering, pp. 125, Beijing, 1993.

Ye, Q., Kang, F.X., Lu, S.C.,

Tao, J.M.

, Zhang, S.L., and Yu, J.T. Continuous and high cell density

cultivation of

E. coli

W3110 (pEC901) harboring human interferon alpha A gene. Biochemical

Engineering for 2001 (Proceedings of Asia-Pacific Biochemical Engineering Conference '92), pp. 221,

Yokohama, 1992.

AOAC OMB Meeting Book

269